好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Spastic Paraparesis in a Patient with Homozygous SPG7 mutation
Neuromuscular and Clinical Neurophysiology (EMG)
P1 - Poster Session 1 (9:00 AM-5:00 PM)
391
Characterize the clinical presentation caused by a homozygous mutation in spastic paraplegia 7 gene (SPG7) encoding paraplegin responsible for autosomal recessive hereditary spasticity.
Late-onset paraplegia with ataxia is rare and requires extensive investigations. Genetic testing has revealed the overlap between hereditary spastic paraplegia and hereditary cerebellar ataxia, caused by multiple mutations in SPG7. The genotype-phenotype correlations caused by SPG7 mutations are not well established.
N/A

We report a 56-year-old right-handed man, previously healthy, who presented with one year of progressive stiffness and pain of his right leg after walking. His motor and cognitive development were normal. Family history was negative for neuromuscular disorders, but consanguinity was present.

His stature was short, face and chin small, and palate highly arched. He had limited upgaze, bilateral fixed ptosis, saccadic eye pursuit and facial weakness. Muscle tone was increased in legs. There was bilateral mild weakness of hip flexion, hip abduction, knee flexion, ankle dorsiflexion, toe extension and flexion, worse on right. Sensory examination was normal. Jaw jerk was normal. Pectoralis reflex was brisk. Deep tendon reflexes were 2+ in upper extremities and 3+ at patella and ankle bilaterally. Plantar reflexes were downgoing. Gait was wide based, spastic with right leg circumduction.

Metabolic panel, complete blood count, HbA1C, thyroid panel, vitamin B12, folate, and testosterone were normal. Acetylcholine receptor blocking antibodies, MUSK antibodies, antinuclear antibodies, RPR, FTA-Abs were negative.

Brain MRI showed cerebellar atrophy and cervical spine MRI mild disk bulges. NCS/EMG revealed non irritative myopathic changes in facial muscles. Single fiber EMG of right frontalis was abnormal. 

Genetic testing was positive for homozygous pathogenic variant in SPG7, c.233T>A, (p.Leu78Ter) in exon2, responsible for spastic paraplegia type 7 related disorders.


Our case emphasizes the need for genetic investigation in patients with unexplained late onset paraparesis and contributes to characterization of SPG associated disorders.
Authors/Disclosures
Sabrina Bulancea
PRESENTER
Sabrina Bulancea has nothing to disclose.
Adrian Marchidann, MD (Kings County Hospital) Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Daphne Robakis, MD (Sanofi) Dr. Robakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal pharmaceuticals.
James Hiana, MD Dr. Hiana has nothing to disclose.